| 0 (0%) | 04-26 09:44 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 202.01 | 1-year : | 214.73 |
| Resists | First : | 172.95 | Second : | 183.85 |
| Pivot price | 164.75 |
|||
| Supports | First : | 155.33 | Second : | 129.24 |
| MAs | MA(5) : | 163.28  |
MA(20) : | 167.42 |
| MA(100) : | 154.41 |
MA(250) : | 145.58 |
|
| MACD | MACD : | -2.3 |
Signal : | -1.7 |
| %K %D | K(14,3) : | 43.7 |
D(3) : | 42.3 |
| RSI | RSI(14): 42.5 |
|||
| 52-week | High : | 183.85 | Low : | 97.18 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ RRX ] has closed above bottom band by 35.4%. Bollinger Bands are 10.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 163.87 - 164.76 | 164.76 - 165.51 |
| Low: | 158.03 - 159.15 | 159.15 - 160.09 |
| Close: | 160.27 - 161.99 | 161.99 - 163.42 |
Wed, 03 Jan 2024
UCB agrees to acquire Ra Pharmaceuticals: Joining forces to improve treatment options for people living with ... - UCB
Fri, 21 Oct 2022
Reducing noise pollution with acoustic walls and rubberised roads - ScienceBlog.com
Thu, 26 Aug 2021
Aoife Brennan - Irish America
Fri, 09 Oct 2020
Novel asphalt additive for better, safer and environment-friendly roads - Cordis News
Thu, 10 Oct 2019
Ra Pharma Stock Doubles On $2.5B Buyout Deal With Belgian Biopharma UCB - UCB (OTC:UCBJF) - Benzinga
Thu, 10 Oct 2019
Why Ra Pharmaceuticals Is Skyrocketing Today - The Motley Fool
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 67 (M) |
| Shares Float | 66 (M) |
| Held by Insiders | 0.5 (%) |
| Held by Institutions | 101 (%) |
| Shares Short | 1,210 (K) |
| Shares Short P.Month | 1,220 (K) |
| EPS | -0.87 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 95.69 |
| Profit Margin | -1 % |
| Operating Margin | 13.6 % |
| Return on Assets (ttm) | 3.4 % |
| Return on Equity (ttm) | -0.9 % |
| Qtrly Rev. Growth | 29.2 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 93.98 |
| EBITDA (p.s.) | 17.74 |
| Qtrly Earnings Growth | -45.5 % |
| Operating Cash Flow | 715 (M) |
| Levered Free Cash Flow | 427 (M) |
| PE Ratio | -188.34 |
| PEG Ratio | 1 |
| Price to Book value | 1.69 |
| Price to Sales | 1.72 |
| Price to Cash Flow | 15.05 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|